Autologous and allogeneic blood transfusions in colorectal cancer
Since blood transfusion became a therapeutical option in patient care, the surgical possibilities have increased tremendously. Since the problems of anticoagulation and blood group typing were largely resolved, blood transfusions were in only a minority of cases directly lethal. However, it was estimated that still up to 20% of the blood transfusions induces a sort of adverse side-effect. Because the most important side-effects are a result of the transmission of infections and the induction of immunological reactions, these are further discussed.
|Publisher||Erasmus University (Institute)|
|Promotor||Jeekel, J. (Hans)|
|Sponsor||Dutch Cancer Society (KWF), Dutch Foundation for Preventive Medicine|
|Keywords||autologous blood transfusion, colorectal cancer, hematology, immunology|
Busch, O.R.C.. (1995, June 8). Autologous and allogeneic blood transfusions in colorectal cancer. Erasmus University (Institute). Retrieved from http://hdl.handle.net/1765/21761